Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1

Neoplasma

Volumn 62, Issue 4, 2015, Pages 541-549

  Wang, C H ^a   Yan, G ^b   Zhang, Y Q ^a   Jia, X Q ^a   Bu, P ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b Huaian Hospital   (China)

Author keywords

Long noncoding RNA; MEG3; Metastasis; RAC1; Thyroid cancer

Indexed keywords

LONG UNTRANSLATED RNA; MEG3 PROTEIN; PROTEIN; RAC1 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; WESTERN BLOTTING;

EID: 84942252302     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_065     Document Type: Article

References (31)

1. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN. International journal of cancer 2008; 127: 2893–2917. http://dx.doi.org/10.1002/ijc.25516
2. Qian BY, HEM M, DONG SF, WANG JF, Chen KX, Incidence and mortality of thyroid cancers in Tianjin from 1981 to 2001. Chin JEndocrinolM etab 2005; 21: 432–434.
3. PERRI F, LORENZO G.D, SCARPATI GD, BUONERBA C Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options. World journal of clinical oncology 2011; 2: 150–157. http://dx.doi.org/10.5306/wjco.v2.i3.150
4. Malone CD, HANNON GJ, Small RNAs as guardians of the genome. Cell 2009; 136: 656–668.
5. MOAZED D. Small RNAs in transcriptional gene silencing and genome defence. Nature 2009; 457: 413–420. http://dx.doi.org/10.1038/nature07756
6. BROSNAN CA, VOINNET O. The long and the short of noncoding RNAs. Curr. Opin. Cell Biol 2009; 21: 416–425. http://dx.doi.org/10.1016/j.ceb.2009.04.001
7. MATTICK JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Reports 2001; 2: 986–991. http://dx.doi.org/10.1093/embo-reports/kve230
8. KOBAYSSHI S, WAGATSUMA H, ONO R, ICHIKAWA H, Yamazaki M et al. Mouse Peg9/Dlk1 and human PEG9/DLK1 are paternally expressed imprinted genes closely located to the maternally expressed imprinted genes: mouse Meg3/Gtl2 and human MEG3. Genes Cells. 2000; 5: 1029–37. http://dx.doi.org/10.1046/j.1365-2443.2000.00390.x
9. Yan J, Guo X, Xia J, Shan T, Gu C et al. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol. 2014; 31(3): 879. http://dx.doi.org/10.1007/s12032-014-0879-6
10. Jia LF, Wei SB, Gao Y, Gan YH, Gong K et al. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer. 2013 Dec 16. http://dx.doi.org/10.1002/ijc.28667
11. Ribarska T, Goering W, Droop J, Bastian KM, Ingenwerth M et al. Deregulation of an imprinted gene network in prostate cancer. BMC Cancer. 2013 7;13:461.
12. Lu KH, Li W, Liu XH, Sun M, Zhang ML et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. Tumour Biol. 2014; 35: 1065–73.
13. YING L, HUANG Y, CHEN H, WANG Y, XIA L et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 2013; 9: 407–411. http://dx.doi.org/10.1039/c2mb25386k
14. BALIK V, SROVNAL J, SULLA I, KALITA O, FOLTANOVA T, et al. MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. J.Neurooncol. 2013; 112: 1–8 http://dx.doi.org/10.1007/s11060-012-1038-6
15. Wang P, Ren Z, Sun Pang P Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012 Jun; 113: 1868–74. http://dx.doi.org/10.1002/jcb.24055
16. W. Zhao, Y. AN, Y. LIANG, X.W. XIE, Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. European Review for Medical and Pharmacological Sciences. 2014; 18: 1930–1936.
17. Zhang J, Socolovsky M, Gross A, LODISH HF Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 102: 3938–3946, 2003. http://dx.doi.org/10.1182/blood-2003-05-1479
18. GUTSCHNER T, DIEDERICHS S The Hallmarks of Cancer. a long non-coding RNA point of view. RNA Biol 2012; 9: 703–719. http://dx.doi.org/10.4161/rna.20481
19. Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R Rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 1989; 264: 16378–16382.
20. Del Pozo MA, Price LS, Alderson NB, Ren XD, Schwartz MA Adhesion to the extracellular matrix regulates the coupling of the small GTPase Rac to its effector PAK. EMBO J 2000; 19: 2008–2014. http://dx.doi.org/10.1093/emboj/19.9.2008
21. Chung CY, Lee S, Briscoe C, Ellsworth C, Firtel RA, Role of Rac in controlling the actin cytoskeleton and chemotaxis in motile cells. Proc Natl Acad Sci USA 2000; 97: 5225–5230. http://dx.doi.org/10.1073/pnas.97.10.5225
22. Zhao SY, Sun Y, Lai ZS, Nan QZ, Li K, et al. Inhibition of migration and invasion of colorectal cancer cells via deletion of Rac1 with RNA interference. Mol Cell Biochem 2009; 322: 179–84. http://dx.doi.org/10.1007/s11010-008-9955-6
23. Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY, et al. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. Int J Mol Med 2011; 24: 769–76.
24. ZHEN C, CHEN L, ZHAO Q, LIANG B, GU YX, et al. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene 2013; 32: 3452–60. http://dx.doi.org/10.1038/onc.2012.356
25. Hernandez E, De La Mota-Peynado A, Dharmawardhane S, Vlaar CP, Novel inhibitors of Rac1 in metastatic breast cancer. P R Health Sci J 2010; 29: 348–56.
26. Kamai T, Shirataki H, Nakanishi K, Furuya N, Kambara T, et al. Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer 2010; 10: 164. http://dx.doi.org/10.1186/1471-2407-10-164
27. Yap LF, Jenei V, Robinson CM, Moutasim K, Benn TM, et al. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation. Oncogene 2009; 28: 2524–34. http://dx.doi.org/10.1038/onc.2009.105
28. Wang P, Chen L, Zhang J, Chen H, Fan J, et al. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene 2013; 21. http://dx.doi.org/10.1038/onc.2012.598
29. Imam JS, Plyler JR, Bansal H, Prajapati S, Bansal S, et al. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One 2012; 7: e52397. http://dx.doi.org/10.1371/journal.pone.0052397
30. Zhou Y, Su J, Shi L, Liao Q, Su Q, DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncol Rep 2013, 29: 605–12.
31. GUPTA GP, MASSAGUE J Cancer metastasis: building a framework. Cell 2006; 127: 679–695. http://dx.doi.org/10.1016/j.cell.2006.11.001